Vol. XV no. 3 Journal of Law & Policy (2007)

Regulating Pharmaceuticals and Scientific Issues Regarding Asbestos Introduction by Margaret A. Berger When Evidence Isn't: Trials, Drugs Companies and the FDA Drummond Rennie, M.D., F.R.D.C.P., M.A.C.P. Federalism in Action: FDA Regulatory Preemption in Pharmaceutical Cases in State Versus Federal Courts Catherine M. Sharkey Enhancing Drug Effectiviness and Efficacy Through Personal Injury Litigation Anita Bernstein Prescription Drug Systems and Price Control in Canada Robert S. Nakagawa Asbestos and Causation of Non-Respiratory Cancers: Evaluation by the Institute of medicine Jonathan M. Samet, M.D., M.S. How Litigation Shapes the Scientific Literature: Asbestos & Disease Among Automovile Mechanics David Michaels, Ph.D., M.P.H. & Celeste Monforton, M.P.H. Federal Asbestos Legislation: Wrestling With The Medical Issues Patrick M. Hanlon Asbestos Litigation in New South Wales Hon. John Lawrence O'Meally

Vol. XV no. 1 Journal of Law & Policy (2007)

Evaluating Evidence of Causation & Forensic Laboratories: Current Issues & Standards Introduction by Margaret A. Berger A Framework for Assessing Scientific Arguments: Gaps, Relevance and Integrated Evidence Carl F. Cranor, Ph.D., M.S.L. Regulating Crime Laboratories: The Impact of DNA Evidence Paul C. Giannelli, J.D., M.S. Judgment for Judges: What Traditional Statistics Don't Tell You About Causal Claims Steven N. Goodman, M.D. Determining Disease: Causality From Experimental Toxicology Studies Ronald L. Melnick, Ph.D. & John R. Bucher, Ph.D. The Nature and Necessity of Scientific Judgment Douglas L. Weed, M.D., Ph.D.

Vol. XIV no. 2 Journal of Law & Policy (2006)

Techniques For Evidence-Based Medicine Introduction by Margaret A. Berger Helping Public Officials Use Research Evaluating Healthcare Daniel M. Fox, Ph.D. & Lee Greenfield, B.S When Good Information Truly Matters: Public Sector Decision Makers Acquiring And Using Research To Inform Their Decisions Mark Gibson Evaluating Systematic Reviews And Meta-Analyses Lisa A. Bero, Ph.D. When There Are No Randomized Controlled Trials: A Case History Of A Controversial Procedure For Metastatic Breast Cancer Jeffrey C. Lerner, Ph.D. & Diane C. Robertson

Vol. XIV no. 1 Journal of Law & Policy (2005)

Risk Assessment Data: Disclosure and Protection Introduction by Margaret A. Berger Genetic Data in Toxic Tort Litigation Gary E. Marchant, Ph.D Evaluating Disease Causation in Humans Exposed to Toxic Substances Joseph V. Rodricks, Ph.D., D.A.B.T Doubting Daubert Lisa Heinzerling Access to Research Data: Reconciling Risks and Benefits Eleanor Singer, Ph.D. Balancing Access to Government-Controlled Information Alan B. Morrison, L.L.B Judging Science: An Essay on the Unscientific Basis of Beliefs about the Impact of Legal Rules on Science and the Need for Better Data about Law Gillian K. Hadfield, Ph.D The Dangers of Daubert Creep in the Regulatory Realm Claire R. Kelly

Vol. XIII no. 2 Journal of Law & Policy (2005)

Agent Orange Revisited and Human Behavior Research Introduction by Margaret A. Berger Characterization of Exposure to Agent Orange in Vietnam Veterans as a Basis for Epidemiological Studies Jeanne Mager Stellman, Ph.D., & Steven D. Stellman, Ph.D., M.P.H. * Erratum Connections: The Early History of Scientific and Medical Research on “Agent Orange” David A. Butler, Ph.D. How Scientists View Causality and Assess Evidence: A Study of the Institute of Medicine’s Evaluation of Health Effects in Vietnam Veterans and Agent Orange Irva Hertz-Picciotto, Ph.D., M.P.H. The Role of Science in Department of Veterans Affairs Disability Compensation Policies for Environmental and Occupational Illnesses and Injuries Mark Brown, Ph.D. On the Use of Gender Stereotyping Research in Sex Discrimination Litigation Eugene Borgida, Ph.D., Corrie Hunt, and Anita Kim Assessing The Likelihood of Future Violence in Individuals with Mental Illness: Current Knowledge and Future Issues Edward P. Mulvey, Ph.D.

Vol. XIII no. 1 Journal of Law & Policy (2005)

Science for Judges III: Maintaining the Integrity of Scientific Research and Forensic Evidence in Criminal Proceedings Introduction by Margaret A. Berger Maintaining the Integrity of Scientific Research David Korn, M.D. Scientific Evidence in the Regulatory System: Manufacturing Uncertainty and the Demise of the Formal Regulatory System David Michaels, M.P.H., Ph.D. & Celeste Monforton, M.P.H. The Funding Effect in Science and Its Implications for the Judiciary Sheldon Krimsky, Ph.D. Nuclear and Mitochondrial DNA in the Courtroom Julian Adams, Ph.D. Mitochondrial DNA: Emerging Legal Issues Edward K. Cheng Compositional Analysis of Bullet Lead as Forensic Evidence Michael O. Finkelstein & Bruce Levin, Ph.D. Fingerprint Evidence Sandy L. Zabell, Ph.D.

Vol. XII no. 2 Journal of Law & Policy (2004)

Science for Judges II: The Practice of Epidemiology and Administrative Agency Created Science Introduction by Margaret A. Berger Overview of Research Design in Epidemiology John Concato, M.D., M.S., M.P.H. Systematic Review of Medical Evidence John P.A. Ioannidis, M.D. & Joseph Lau, M.D. Should Compensation Schemes Be Based on the Probability of Causation or Expected Years of Life Lost? James Robins FDA Regulatory Requirements as Tort Standards Richard Merrill What is the Value of an FDA Approval in a Judicial Matter? Michael A. Friedman, M.D. Science and EPA Decision-Making Robert M. Sussman Importing Daubert to Administrative Agencies Through the Information Quality Act Wendy E. Wagner Welfare State or Welfare Court: Asbestos Litigation in Comparative Perspective Sheila Jasanoff & Dogan Perese

Vol. XII no. 1 Journal of Law & Policy (2003)

Science for Judges I: Papers on Toxicology and Epidemiology Introduction by Margaret A. Berger Scientific Judgment and Toxic Torts— A Primer in Toxicology for Judges and Lawyers David L. Eaton, Ph.D., DABT, FATS Causation: An Epidemiologic Perspective (In Five Parts) Douglas L. Weed, M.D., Ph.D